Estrogen-only hormone therapy associated with lower risk of dementia
Peer-Reviewed Publication
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Updates every hour. Last Updated: 27-Oct-2026 22:16 ET (28-Oct-2026 02:16 GMT/UTC)
People with both atrial fibrillation and Alzheimer’s disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline. This is shown by a study from Karolinska Institutet published in the European Heart Journal.
A survey commissioned by The Ohio State University Wexner Medical Center found 60% of Americans want to prioritize brain health earlier in life but don’t know how.
Ohio State neurologist Douglas Scharre, MD, says regular exercise, quality sleep, healthy eating and strong social connections can help support long-term brain health.
The SAGE test can help detect early memory and thinking changes when treatment may be most effective.
A team of scientists from the University of Liège (GIGA Neurosciences), supported by the Stop Alzheimer’s Foundation, has analysed the sleep patterns of more than 500 healthy people. Among middle-aged participants, a higher frequency of nocturnal micro-awakenings was found to be associated with a greater genetic risk of developing Alzheimer’s disease, whereas this link was not observed in young adults. This research, published in the journal Sleep, suggests that the study of sleep could, in the long term, contribute to the early identification of vulnerable individuals.
UC San Diego researchers have found a "genetic switch" triggering neurodegeneration in both a rare childhood dementia and Alzheimer's disease, pointing to new drug targets in the waste-processing system within the brain’s immune cells.